Investor Presentaiton

Kwality - A Niche Injectable Player for Emerging Markets D India's Leading injectable player with a strong presence in emerging markets Strong focus on complex injectables like Liposomal, peptide-based, protein- based, and lyophilized injectables Strong portfolio of 600 products and a pipeline of 300 products under registration. KII 010101 An experienced team led by visionary management State of art manufacturing for Critical care, Oncology, General & Cephalosporin injectables Superior financials - FY22 Revenues: 74% EBTIDA: 38.4%, ROE: 66% 3

View entire presentation